Zinc bioavailability in feed-grade sources of zinc.
Chick bioassays were used to assess bioavailability of zinc (Zn) from inorganic Zn sources. A soy isolate-dextrose diet containing 13 mg Zn/kg diet was supplemented with feed-grade sources of ZnSO4.H2O (ZnSO4) or ZnO and fed for 2 wk after a 7-d Zn-depletion protest period. Bioavailability of Zn in ZnO relative to ZnSO4 (set at 100%) was determined by multiple regression slope-ratio methodology, using both growth and tibia Zn accumulation in chicks fed graded levels of ZnO and ZnSO4. Linear responses for gain and tibia Zn occurred at dietary Zn levels (ZnSO4.7H2O) between 13 mg/kg (basal) and 33 mg/kg (gain) or 53 mg/kg (total tibia Zn). Therefore, two bioavailability assays were conducted using supplemental Zn levels of 0, 7.5 and 15 mg/kg from each Zn source. When weight gain was regressed on supplemental Zn intake, bioavailability of Zn in ZnO was only 61.2% (P less than .01) that of ZnSO4. When total tibia Zn was regressed on supplemental Zn intake, bioavailability of Zn compared with ZnSO4 (set at 100.0%) was 44.1% (P less than .001) for ZnO. With chicks fed soy-based diets, bioavailability of Zn from ZnO was less than that of ZnSO4.
Wedekind
K J
KJ
Dept. of Anim. Sci., University of Illinois, Urbana 61801.
Baker
D H
DH
D000821:Animal Feed; D000818:Animals; D001682:Biological Availability; D002645:Chickens / Q000378:metabolism*; D004032:Diet; D004435:Eating; D008297:Male; D012044:Regression Analysis; D013431:Sulfates / Q000493:pharmacokinetics; D013977:Tibia / Q000378:metabolism; D015430:Weight Gain / Q000187:drug effects; D015032:Zinc / Q000493:pharmacokinetics*; D015034:Zinc Oxide / Q000493:pharmacokinetics; D019287:Zinc Sulfate
D013431:Sulfates; D019287:Zinc Sulfate; D015032:Zinc; D015034:Zinc Oxide